CA2577470A1 - Fiber-modified adenoviral vectors for enhanced transduction of tumor cells - Google Patents

Info

Publication number

CA2577470A1

CA2577470A1 CA002577470A CA2577470A CA2577470A1 CA 2577470 A1 CA2577470 A1 CA 2577470A1 CA 002577470 A CA002577470 A CA 002577470A CA 2577470 A CA2577470 A CA 2577470A CA 2577470 A1 CA2577470 A1 CA 2577470A1

Authority

CA

Canada

Prior art keywords

cell

cells

adenovirus

tre

tumor

Prior art date

2004-08-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 239000013598 vector Substances 0.000 title abstract description 255
• 210000004881 tumor cell Anatomy 0.000 title abstract description 222
• 238000010361 transduction Methods 0.000 title description 43
• 230000026683 transduction Effects 0.000 title description 43
• 241000701161 unidentified adenovirus Species 0.000 abstract description 170
• 101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 abstract description 19
• 102100039373 Membrane cofactor protein Human genes 0.000 abstract description 19
• 108700026758 Adenovirus hexon capsid Proteins 0.000 abstract description 7
• 210000004027 cell Anatomy 0.000 description 434
• 206010028980 Neoplasm Diseases 0.000 description 185
• 108090000623 proteins and genes Proteins 0.000 description 178
• 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 149
• 241001135569 Human adenovirus 5 Species 0.000 description 105
• 108700019146 Transgenes Proteins 0.000 description 93
• 201000011510 cancer Diseases 0.000 description 76
• 230000010076 replication Effects 0.000 description 75
• 108091026890 Coding region Proteins 0.000 description 72
• 239000000835 fiber Substances 0.000 description 70
• 102000004169 proteins and genes Human genes 0.000 description 69
• 230000014509 gene expression Effects 0.000 description 65
• 235000018102 proteins Nutrition 0.000 description 65
• 101710145505 Fiber protein Proteins 0.000 description 62
• 241000282414 Homo sapiens Species 0.000 description 62
• 241000700605 Viruses Species 0.000 description 61
• 238000000034 method Methods 0.000 description 58
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 55
• 102000004127 Cytokines Human genes 0.000 description 54
• 108090000695 Cytokines Proteins 0.000 description 54
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 54
• 210000003128 head Anatomy 0.000 description 54
• 150000007523 nucleic acids Chemical class 0.000 description 49
• 239000002245 particle Substances 0.000 description 49
• 150000001413 amino acids Chemical group 0.000 description 46
• 238000003776 cleavage reaction Methods 0.000 description 46
• 230000007017 scission Effects 0.000 description 46
• 108091028043 Nucleic acid sequence Proteins 0.000 description 43
• 239000012634 fragment Substances 0.000 description 41
• 108020004414 DNA Proteins 0.000 description 40
• 239000000427 antigen Substances 0.000 description 37
• 108091007433 antigens Proteins 0.000 description 37
• 102000036639 antigens Human genes 0.000 description 37
• 239000013612 plasmid Substances 0.000 description 37
• 230000028993 immune response Effects 0.000 description 36
• 201000001441 melanoma Diseases 0.000 description 36
• 230000000981 bystander Effects 0.000 description 34
• 102000039446 nucleic acids Human genes 0.000 description 34
• 108020004707 nucleic acids Proteins 0.000 description 34
• 238000012545 processing Methods 0.000 description 33
• 230000000735 allogeneic effect Effects 0.000 description 32
• 239000000203 mixture Substances 0.000 description 32
• 102000040430 polynucleotide Human genes 0.000 description 31
• 108091033319 polynucleotide Proteins 0.000 description 31
• 239000002157 polynucleotide Substances 0.000 description 31
• 229940024606 amino acid Drugs 0.000 description 29
• 210000001519 tissue Anatomy 0.000 description 29
• 235000001014 amino acid Nutrition 0.000 description 28
• 239000002773 nucleotide Substances 0.000 description 28
• 125000003729 nucleotide group Chemical group 0.000 description 28
• 241000124008 Mammalia Species 0.000 description 27
• 238000012217 deletion Methods 0.000 description 27
• 230000037430 deletion Effects 0.000 description 27
• 239000003623 enhancer Substances 0.000 description 27
• 108090000765 processed proteins & peptides Proteins 0.000 description 27
• 238000013518 transcription Methods 0.000 description 27
• 230000035897 transcription Effects 0.000 description 27
• 230000001105 regulatory effect Effects 0.000 description 26
• 239000013603 viral vector Substances 0.000 description 25
• 230000003612 virological effect Effects 0.000 description 25
• 208000014829 head and neck neoplasm Diseases 0.000 description 24
• 230000001225 therapeutic effect Effects 0.000 description 24
• 101710197337 Adenovirus death protein Proteins 0.000 description 23
• 238000003752 polymerase chain reaction Methods 0.000 description 23
• 238000011282 treatment Methods 0.000 description 23
• 230000000694 effects Effects 0.000 description 22
• 230000006870 function Effects 0.000 description 22
• 102000004196 processed proteins & peptides Human genes 0.000 description 22
• 239000005090 green fluorescent protein Substances 0.000 description 20
• 201000010536 head and neck cancer Diseases 0.000 description 20
• 208000015181 infectious disease Diseases 0.000 description 20
• 101150075174 E1B gene Proteins 0.000 description 19
• 238000000338 in vitro Methods 0.000 description 19
• 229920001184 polypeptide Polymers 0.000 description 19
• 239000000047 product Substances 0.000 description 19
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 17
• 102000046157 human CSF2 Human genes 0.000 description 17
• 239000003446 ligand Substances 0.000 description 16
• -1 rRNA Proteins 0.000 description 16
• 102000005962 receptors Human genes 0.000 description 15
• 108020003175 receptors Proteins 0.000 description 15
• 238000013519 translation Methods 0.000 description 15
• 238000013459 approach Methods 0.000 description 14
• 230000004048 modification Effects 0.000 description 14
• 238000012986 modification Methods 0.000 description 14
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
• 102000040945 Transcription factor Human genes 0.000 description 13
• 108091023040 Transcription factor Proteins 0.000 description 13
• 238000001727 in vivo Methods 0.000 description 13
• 230000000174 oncolytic effect Effects 0.000 description 13
• 238000011144 upstream manufacturing Methods 0.000 description 13
• 108091081024 Start codon Proteins 0.000 description 12
• 210000005260 human cell Anatomy 0.000 description 12
• 230000001965 increasing effect Effects 0.000 description 12
• 210000004962 mammalian cell Anatomy 0.000 description 12
• 230000002103 transcriptional effect Effects 0.000 description 12
• 229960005486 vaccine Drugs 0.000 description 12
• 206010060862 Prostate cancer Diseases 0.000 description 11
• 230000001413 cellular effect Effects 0.000 description 11
• 238000002347 injection Methods 0.000 description 11
• 239000007924 injection Substances 0.000 description 11
• 101150045895 Apela gene Proteins 0.000 description 10
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
• 102000013392 Carboxylesterase Human genes 0.000 description 10
• 108010051152 Carboxylesterase Proteins 0.000 description 10
• 229940032072 GVAX vaccine Drugs 0.000 description 10
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 10
• 201000010099 disease Diseases 0.000 description 10
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
• 210000002752 melanocyte Anatomy 0.000 description 10
• 230000035755 proliferation Effects 0.000 description 10
• 230000009885 systemic effect Effects 0.000 description 10
• 102100032187 Androgen receptor Human genes 0.000 description 9
• 201000009030 Carcinoma Diseases 0.000 description 9
• 101710138647 Protein tyrosine phosphatase type IVA 3 Proteins 0.000 description 9
• 108010080146 androgen receptors Proteins 0.000 description 9
• 230000012010 growth Effects 0.000 description 9
• 239000001963 growth medium Substances 0.000 description 9
• 210000000987 immune system Anatomy 0.000 description 9
• 238000004519 manufacturing process Methods 0.000 description 9
• 239000002953 phosphate buffered saline Substances 0.000 description 9
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 9
• 102000004190 Enzymes Human genes 0.000 description 8
• 108090000790 Enzymes Proteins 0.000 description 8
• 102100040247 Tumor necrosis factor Human genes 0.000 description 8
• 230000008901 benefit Effects 0.000 description 8
• 230000000295 complement effect Effects 0.000 description 8
• 230000001472 cytotoxic effect Effects 0.000 description 8
• 230000003013 cytotoxicity Effects 0.000 description 8
• 231100000135 cytotoxicity Toxicity 0.000 description 8
• 230000002950 deficient Effects 0.000 description 8
• 229940088598 enzyme Drugs 0.000 description 8
• 239000012091 fetal bovine serum Substances 0.000 description 8
• 230000006801 homologous recombination Effects 0.000 description 8
• 238000002744 homologous recombination Methods 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 230000037431 insertion Effects 0.000 description 8
• 210000004072 lung Anatomy 0.000 description 8
• 208000020816 lung neoplasm Diseases 0.000 description 8
• 108091008146 restriction endonucleases Proteins 0.000 description 8
• 238000006467 substitution reaction Methods 0.000 description 8
• 239000000725 suspension Substances 0.000 description 8
• 108010006303 Carboxypeptidases Proteins 0.000 description 7
• 102000005367 Carboxypeptidases Human genes 0.000 description 7
• 241000588724 Escherichia coli Species 0.000 description 7
• 208000008839 Kidney Neoplasms Diseases 0.000 description 7
• 206010038389 Renal cancer Diseases 0.000 description 7
• 210000000612 antigen-presenting cell Anatomy 0.000 description 7
• 239000006285 cell suspension Substances 0.000 description 7
• 230000001419 dependent effect Effects 0.000 description 7
• 230000001976 improved effect Effects 0.000 description 7
• 239000002609 medium Substances 0.000 description 7
• 108020004999 messenger RNA Proteins 0.000 description 7
• 238000002360 preparation method Methods 0.000 description 7
• 210000002307 prostate Anatomy 0.000 description 7
• 102100026189 Beta-galactosidase Human genes 0.000 description 6
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 6
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 6
• 108020004705 Codon Proteins 0.000 description 6
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• 102000004961 Furin Human genes 0.000 description 6
• 108090001126 Furin Proteins 0.000 description 6
• 101710177565 Gliomedin Proteins 0.000 description 6
• 102100024601 Protein tyrosine phosphatase type IVA 3 Human genes 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• 210000001744 T-lymphocyte Anatomy 0.000 description 6
• 108010017842 Telomerase Proteins 0.000 description 6
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 6
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 6
• 102000004504 Urokinase Plasminogen Activator Receptors Human genes 0.000 description 6
• 108010042352 Urokinase Plasminogen Activator Receptors Proteins 0.000 description 6
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 6
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 6
• 238000003556 assay Methods 0.000 description 6
• 108010005774 beta-Galactosidase Proteins 0.000 description 6
• 239000002299 complementary DNA Substances 0.000 description 6
• 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 6
• 230000029087 digestion Effects 0.000 description 6
• 230000001939 inductive effect Effects 0.000 description 6
• 210000005170 neoplastic cell Anatomy 0.000 description 6
• 208000008443 pancreatic carcinoma Diseases 0.000 description 6
• 210000003491 skin Anatomy 0.000 description 6
• 210000002845 virion Anatomy 0.000 description 6
• HXNBAOLVPAWYLT-NVNXTCNLSA-N (5z)-5-[[5-bromo-2-[(2-bromophenyl)methoxy]phenyl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound S\1C(=S)NC(=O)C/1=C/C1=CC(Br)=CC=C1OCC1=CC=CC=C1Br HXNBAOLVPAWYLT-NVNXTCNLSA-N 0.000 description 5
• 108090000565 Capsid Proteins Proteins 0.000 description 5
• 102100023321 Ceruloplasmin Human genes 0.000 description 5
• 239000012981 Hank's balanced salt solution Substances 0.000 description 5
• 108010002350 Interleukin-2 Proteins 0.000 description 5
• 102000000588 Interleukin-2 Human genes 0.000 description 5
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 5
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 5
• 206010027476 Metastases Diseases 0.000 description 5
• 108700026244 Open Reading Frames Proteins 0.000 description 5
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 5
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 5
• 102100038358 Prostate-specific antigen Human genes 0.000 description 5
• 108700009124 Transcription Initiation Site Proteins 0.000 description 5
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 5
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 5
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 5
• 230000001594 aberrant effect Effects 0.000 description 5
• 229940030156 cell vaccine Drugs 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 238000010276 construction Methods 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 230000002519 immonomodulatory effect Effects 0.000 description 5
• 239000003112 inhibitor Substances 0.000 description 5
• 201000010982 kidney cancer Diseases 0.000 description 5
• 210000004185 liver Anatomy 0.000 description 5
• 201000007270 liver cancer Diseases 0.000 description 5
• 208000014018 liver neoplasm Diseases 0.000 description 5
• 201000005202 lung cancer Diseases 0.000 description 5
• 210000002540 macrophage Anatomy 0.000 description 5
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 5
• 201000002528 pancreatic cancer Diseases 0.000 description 5
• 230000008685 targeting Effects 0.000 description 5
• CXURGFRDGROIKG-UHFFFAOYSA-N 3,3-bis(chloromethyl)oxetane Chemical compound ClCC1(CCl)COC1 CXURGFRDGROIKG-UHFFFAOYSA-N 0.000 description 4
• 108020005029 5' Flanking Region Proteins 0.000 description 4
• IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 4
• 241000283690 Bos taurus Species 0.000 description 4
• 102000000844 Cell Surface Receptors Human genes 0.000 description 4
• 108010001857 Cell Surface Receptors Proteins 0.000 description 4
• 102000029816 Collagenase Human genes 0.000 description 4
• 108060005980 Collagenase Proteins 0.000 description 4
• 206010055114 Colon cancer metastatic Diseases 0.000 description 4
• 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 4
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 4
• 108091054437 MHC class I family Proteins 0.000 description 4
• 206010029260 Neuroblastoma Diseases 0.000 description 4
• 206010033128 Ovarian cancer Diseases 0.000 description 4
• 206010061535 Ovarian neoplasm Diseases 0.000 description 4
• 108091027981 Response element Proteins 0.000 description 4
• 108700005077 Viral Genes Proteins 0.000 description 4
• 125000000539 amino acid group Chemical group 0.000 description 4
• 239000005557 antagonist Substances 0.000 description 4
• 230000000259 anti-tumor effect Effects 0.000 description 4
• 230000015572 biosynthetic process Effects 0.000 description 4
• 210000004369 blood Anatomy 0.000 description 4
• 239000008280 blood Substances 0.000 description 4
• 210000000481 breast Anatomy 0.000 description 4
• 238000009709 capacitor discharge sintering Methods 0.000 description 4
• 229960002424 collagenase Drugs 0.000 description 4
• 210000001072 colon Anatomy 0.000 description 4
• 230000001461 cytolytic effect Effects 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 238000000684 flow cytometry Methods 0.000 description 4
• 239000000411 inducer Substances 0.000 description 4
• 230000002458 infectious effect Effects 0.000 description 4
• 239000002502 liposome Substances 0.000 description 4
• 210000005229 liver cell Anatomy 0.000 description 4
• 238000010369 molecular cloning Methods 0.000 description 4
• 230000035772 mutation Effects 0.000 description 4
• 238000004806 packaging method and process Methods 0.000 description 4
• 108010042121 probasin Proteins 0.000 description 4
• 210000005267 prostate cell Anatomy 0.000 description 4
• 208000023958 prostate neoplasm Diseases 0.000 description 4
• 230000006337 proteolytic cleavage Effects 0.000 description 4
• 238000009877 rendering Methods 0.000 description 4
• 230000003584 silencer Effects 0.000 description 4
• 230000004936 stimulating effect Effects 0.000 description 4
• 210000002784 stomach Anatomy 0.000 description 4
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 238000003786 synthesis reaction Methods 0.000 description 4
• 238000012360 testing method Methods 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• 230000001988 toxicity Effects 0.000 description 4
• 231100000419 toxicity Toxicity 0.000 description 4
• 230000002463 transducing effect Effects 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 206010005003 Bladder cancer Diseases 0.000 description 3
• 206010006187 Breast cancer Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 102100032378 Carboxypeptidase E Human genes 0.000 description 3
• 206010057248 Cell death Diseases 0.000 description 3
• 206010008342 Cervix carcinoma Diseases 0.000 description 3
• 108010012236 Chemokines Proteins 0.000 description 3
• 102000019034 Chemokines Human genes 0.000 description 3
• 206010009944 Colon cancer Diseases 0.000 description 3
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
• 101100440985 Danio rerio crad gene Proteins 0.000 description 3
• 108700039887 Essential Genes Proteins 0.000 description 3
• 201000008808 Fibrosarcoma Diseases 0.000 description 3
• 208000032612 Glial tumor Diseases 0.000 description 3
• 206010018338 Glioma Diseases 0.000 description 3
• 102100039992 Gliomedin Human genes 0.000 description 3
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 3
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 3
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 3
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 3
• 241000701124 Human adenovirus 35 Species 0.000 description 3
• 102000000589 Interleukin-1 Human genes 0.000 description 3
• 108010002352 Interleukin-1 Proteins 0.000 description 3
• 102000004388 Interleukin-4 Human genes 0.000 description 3
• 108090000978 Interleukin-4 Proteins 0.000 description 3
• 108090001005 Interleukin-6 Proteins 0.000 description 3
• 102000004889 Interleukin-6 Human genes 0.000 description 3
• 108091092195 Intron Proteins 0.000 description 3
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
• 102000043129 MHC class I family Human genes 0.000 description 3
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• 102100034256 Mucin-1 Human genes 0.000 description 3
• 102000014842 Multidrug resistance proteins Human genes 0.000 description 3
• 108050005144 Multidrug resistance proteins Proteins 0.000 description 3
• 208000034578 Multiple myelomas Diseases 0.000 description 3
• 101100440987 Mus musculus Cracd gene Proteins 0.000 description 3
• 101100467905 Mus musculus Rdh16 gene Proteins 0.000 description 3
• 102000008299 Nitric Oxide Synthase Human genes 0.000 description 3
• 108010021487 Nitric Oxide Synthase Proteins 0.000 description 3
• 206010035226 Plasma cell myeloma Diseases 0.000 description 3
• 108091034057 RNA (poly(A)) Proteins 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 3
• 102000004338 Transferrin Human genes 0.000 description 3
• 108090000901 Transferrin Proteins 0.000 description 3
• 108090000631 Trypsin Proteins 0.000 description 3
• 102000004142 Trypsin Human genes 0.000 description 3
• 102000012349 Uroplakins Human genes 0.000 description 3
• 108010061861 Uroplakins Proteins 0.000 description 3
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 3
• 238000007792 addition Methods 0.000 description 3
• 208000009956 adenocarcinoma Diseases 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• 230000000118 anti-neoplastic effect Effects 0.000 description 3
• 230000000890 antigenic effect Effects 0.000 description 3
• 230000033228 biological regulation Effects 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 239000012830 cancer therapeutic Substances 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 230000030833 cell death Effects 0.000 description 3
• 230000004663 cell proliferation Effects 0.000 description 3
• 201000010881 cervical cancer Diseases 0.000 description 3
• 238000002512 chemotherapy Methods 0.000 description 3
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 3
• 229960004316 cisplatin Drugs 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 230000008878 coupling Effects 0.000 description 3
• 238000010168 coupling process Methods 0.000 description 3
• 238000005859 coupling reaction Methods 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• 230000000120 cytopathologic effect Effects 0.000 description 3
• 231100000433 cytotoxic Toxicity 0.000 description 3
• 210000004443 dendritic cell Anatomy 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 210000002889 endothelial cell Anatomy 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 229940088597 hormone Drugs 0.000 description 3
• 230000002163 immunogen Effects 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 230000002401 inhibitory effect Effects 0.000 description 3
• 108090000237 interleukin-24 Proteins 0.000 description 3
• 102000003898 interleukin-24 Human genes 0.000 description 3
• 210000003734 kidney Anatomy 0.000 description 3
• 230000003902 lesion Effects 0.000 description 3
• 208000037841 lung tumor Diseases 0.000 description 3
• 210000001165 lymph node Anatomy 0.000 description 3
• 230000009401 metastasis Effects 0.000 description 3
• 210000004882 non-tumor cell Anatomy 0.000 description 3
• 210000000496 pancreas Anatomy 0.000 description 3
• 230000036961 partial effect Effects 0.000 description 3
• 230000001717 pathogenic effect Effects 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 230000004962 physiological condition Effects 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 230000003362 replicative effect Effects 0.000 description 3
• 230000004044 response Effects 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 3
• 235000002639 sodium chloride Nutrition 0.000 description 3
• 239000000243 solution Substances 0.000 description 3
• 238000010561 standard procedure Methods 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 230000001629 suppression Effects 0.000 description 3
• 238000001356 surgical procedure Methods 0.000 description 3
• 208000001608 teratocarcinoma Diseases 0.000 description 3
• 239000012581 transferrin Substances 0.000 description 3
• 230000009261 transgenic effect Effects 0.000 description 3
• 239000012588 trypsin Substances 0.000 description 3
• 201000005112 urinary bladder cancer Diseases 0.000 description 3
• 238000002255 vaccination Methods 0.000 description 3
• 108700026220 vif Genes Proteins 0.000 description 3
• 230000017613 viral reproduction Effects 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
• 108010087905 Adenovirus E1B Proteins Proteins 0.000 description 2
• 102400000068 Angiostatin Human genes 0.000 description 2
• 108010079709 Angiostatins Proteins 0.000 description 2
• 102000013918 Apolipoproteins E Human genes 0.000 description 2
• 108010025628 Apolipoproteins E Proteins 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000894006 Bacteria Species 0.000 description 2
• 102100032407 Carboxypeptidase D Human genes 0.000 description 2
• 108010058255 Carboxypeptidase H Proteins 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 108010079245 Cystic Fibrosis Transmembrane Conductance Regulator Proteins 0.000 description 2
• 102100023419 Cystic fibrosis transmembrane conductance regulator Human genes 0.000 description 2
• 102000000311 Cytosine Deaminase Human genes 0.000 description 2
• 108010080611 Cytosine Deaminase Proteins 0.000 description 2
• 102000004594 DNA Polymerase I Human genes 0.000 description 2
• 108010017826 DNA Polymerase I Proteins 0.000 description 2
• 102100029588 Deoxycytidine kinase Human genes 0.000 description 2
• 108010033174 Deoxycytidine kinase Proteins 0.000 description 2
• 101100044298 Drosophila melanogaster fand gene Proteins 0.000 description 2
• 101150005585 E3 gene Proteins 0.000 description 2
• 102400001047 Endostatin Human genes 0.000 description 2
• 108010079505 Endostatins Proteins 0.000 description 2
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
• 101150064015 FAS gene Proteins 0.000 description 2
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
• 241000714188 Friend murine leukemia virus Species 0.000 description 2
• 108700012941 GNRH1 Proteins 0.000 description 2
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 2
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
• 101710103262 Glandular kallikrein Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
• 208000009889 Herpes Simplex Diseases 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 description 2
• 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 2
• 108091006905 Human Serum Albumin Proteins 0.000 description 2
• 102000008100 Human Serum Albumin Human genes 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
• 102100025390 Integrin beta-2 Human genes 0.000 description 2
• 102000003814 Interleukin-10 Human genes 0.000 description 2
• 108090000174 Interleukin-10 Proteins 0.000 description 2
• 102000013462 Interleukin-12 Human genes 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 108010002616 Interleukin-5 Proteins 0.000 description 2
• 102000000743 Interleukin-5 Human genes 0.000 description 2
• 108010002586 Interleukin-7 Proteins 0.000 description 2
• 102100021592 Interleukin-7 Human genes 0.000 description 2
• 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
• 229930182816 L-glutamine Natural products 0.000 description 2
• 108010001831 LDL receptors Proteins 0.000 description 2
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 2
• 108060001084 Luciferase Proteins 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 2
• 108091054438 MHC class II family Proteins 0.000 description 2
• 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 2
• 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 2
• 108010006035 Metalloproteases Proteins 0.000 description 2
• 102000005741 Metalloproteases Human genes 0.000 description 2
• NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 108010008707 Mucin-1 Proteins 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 241000699660 Mus musculus Species 0.000 description 2
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
• 108010025020 Nerve Growth Factor Proteins 0.000 description 2
• 101710163270 Nuclease Proteins 0.000 description 2
• 101100335198 Pneumocystis carinii fol1 gene Proteins 0.000 description 2
• 108010039918 Polylysine Proteins 0.000 description 2
• 208000037062 Polyps Diseases 0.000 description 2
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
• 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 description 2
• 101710132082 Pyrimidine/purine nucleoside phosphorylase Proteins 0.000 description 2
• 239000012980 RPMI-1640 medium Substances 0.000 description 2
• 208000006265 Renal cell carcinoma Diseases 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
• 108700026226 TATA Box Proteins 0.000 description 2
• 102000006601 Thymidine Kinase Human genes 0.000 description 2
• 108020004440 Thymidine kinase Proteins 0.000 description 2
• 102100031372 Thymidine phosphorylase Human genes 0.000 description 2
• 102000057032 Tissue Kallikreins Human genes 0.000 description 2
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 2
• 102000003425 Tyrosinase Human genes 0.000 description 2
• 108060008724 Tyrosinase Proteins 0.000 description 2
• 208000002495 Uterine Neoplasms Diseases 0.000 description 2
• 108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 2
• 238000002835 absorbance Methods 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 239000003098 androgen Substances 0.000 description 2
• 230000001772 anti-angiogenic effect Effects 0.000 description 2
• 230000001093 anti-cancer Effects 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• 239000002246 antineoplastic agent Substances 0.000 description 2
• 230000005975 antitumor immune response Effects 0.000 description 2
• 230000006907 apoptotic process Effects 0.000 description 2
• FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 2
• 210000003719 b-lymphocyte Anatomy 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 239000000872 buffer Substances 0.000 description 2
• 229940022399 cancer vaccine Drugs 0.000 description 2
• 238000009566 cancer vaccine Methods 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 230000032823 cell division Effects 0.000 description 2
• 230000007910 cell fusion Effects 0.000 description 2
• 230000022534 cell killing Effects 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 239000013553 cell monolayer Substances 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 210000003679 cervix uteri Anatomy 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 210000000448 cultured tumor cell Anatomy 0.000 description 2
• YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 2
• 108010057085 cytokine receptors Proteins 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 229940127089 cytotoxic agent Drugs 0.000 description 2
• 239000003145 cytotoxic factor Substances 0.000 description 2
• 238000000432 density-gradient centrifugation Methods 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 238000010494 dissociation reaction Methods 0.000 description 2
• 230000005593 dissociations Effects 0.000 description 2
• 108010051081 dopachrome isomerase Proteins 0.000 description 2
• 229940079593 drug Drugs 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 210000002615 epidermis Anatomy 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 239000012894 fetal calf serum Substances 0.000 description 2
• XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 2
• 229960004413 flucytosine Drugs 0.000 description 2
• 229960002949 fluorouracil Drugs 0.000 description 2
• 238000010353 genetic engineering Methods 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 208000019691 hematopoietic and lymphoid cell neoplasm Diseases 0.000 description 2
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 230000007954 hypoxia Effects 0.000 description 2
• 230000002637 immunotoxin Effects 0.000 description 2
• 239000002596 immunotoxin Substances 0.000 description 2
• 231100000608 immunotoxin Toxicity 0.000 description 2
• 229940051026 immunotoxin Drugs 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 108010044426 integrins Proteins 0.000 description 2
• 102000006495 integrins Human genes 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 210000005265 lung cell Anatomy 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 238000011580 nude mouse model Methods 0.000 description 2
• 239000003921 oil Substances 0.000 description 2
• 244000309459 oncolytic virus Species 0.000 description 2
• 210000001672 ovary Anatomy 0.000 description 2
• 230000003076 paracrine Effects 0.000 description 2
• 239000003182 parenteral nutrition solution Substances 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 230000035790 physiological processes and functions Effects 0.000 description 2
• 229920000656 polylysine Polymers 0.000 description 2
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 2
• 230000001323 posttranslational effect Effects 0.000 description 2
• 230000001855 preneoplastic effect Effects 0.000 description 2
• 230000002265 prevention Effects 0.000 description 2
• 230000002062 proliferating effect Effects 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 238000001959 radiotherapy Methods 0.000 description 2
• 238000010188 recombinant method Methods 0.000 description 2
• 210000000664 rectum Anatomy 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 201000010174 renal carcinoma Diseases 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 239000000523 sample Substances 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 230000035945 sensitivity Effects 0.000 description 2
• 230000001235 sensitizing effect Effects 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 201000011096 spinal cancer Diseases 0.000 description 2
• 208000014618 spinal cord cancer Diseases 0.000 description 2
• 238000007910 systemic administration Methods 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 102000035160 transmembrane proteins Human genes 0.000 description 2
• 108091005703 transmembrane proteins Proteins 0.000 description 2
• 238000011269 treatment regimen Methods 0.000 description 2
• 238000005829 trimerization reaction Methods 0.000 description 2
• 229940030325 tumor cell vaccine Drugs 0.000 description 2
• 230000005951 type IV hypersensitivity Effects 0.000 description 2
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
• 208000024719 uterine cervix neoplasm Diseases 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
• VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
• 102100027271 40S ribosomal protein SA Human genes 0.000 description 1
• 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 1
• OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
• 208000030507 AIDS Diseases 0.000 description 1
• 108010066676 Abrin Proteins 0.000 description 1
• 206010001258 Adenoviral infections Diseases 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
• 102000009840 Angiopoietins Human genes 0.000 description 1
• 108010009906 Angiopoietins Proteins 0.000 description 1
• 108020004491 Antisense DNA Proteins 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• 102000004411 Antithrombin III Human genes 0.000 description 1
• 108090000935 Antithrombin III Proteins 0.000 description 1
• 241000710189 Aphthovirus Species 0.000 description 1
• 102100029470 Apolipoprotein E Human genes 0.000 description 1
• 101710095339 Apolipoprotein E Proteins 0.000 description 1
• 102000007592 Apolipoproteins Human genes 0.000 description 1
• 108010071619 Apolipoproteins Proteins 0.000 description 1
• 102000018616 Apolipoproteins B Human genes 0.000 description 1
• 108010027006 Apolipoproteins B Proteins 0.000 description 1
• 101100036901 Arabidopsis thaliana RPL40B gene Proteins 0.000 description 1
• 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 102000005427 Asialoglycoprotein Receptor Human genes 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 102100035526 B melanoma antigen 1 Human genes 0.000 description 1
• 208000035143 Bacterial infection Diseases 0.000 description 1
• 208000019838 Blood disease Diseases 0.000 description 1
• 108010051479 Bombesin Proteins 0.000 description 1
• 206010005949 Bone cancer Diseases 0.000 description 1
• 208000018084 Bone neoplasm Diseases 0.000 description 1
• 241000167854 Bourreria succulenta Species 0.000 description 1
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 1
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
• 101710098275 C-X-C motif chemokine 10 Proteins 0.000 description 1
• 102100039398 C-X-C motif chemokine 2 Human genes 0.000 description 1
• 108010041397 CD4 Antigens Proteins 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 description 1
• 101100438971 Caenorhabditis elegans mat-1 gene Proteins 0.000 description 1
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
• 102100029968 Calreticulin Human genes 0.000 description 1
• 108090000549 Calreticulin Proteins 0.000 description 1
• 102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 102400000730 Canstatin Human genes 0.000 description 1
• 101800000626 Canstatin Proteins 0.000 description 1
• 108090000018 Carboxypeptidase D Proteins 0.000 description 1
• 241000710190 Cardiovirus Species 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 102100026548 Caspase-8 Human genes 0.000 description 1
• 108090000538 Caspase-8 Proteins 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 102100035882 Catalase Human genes 0.000 description 1
• 108010053835 Catalase Proteins 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 102100031186 Chromogranin-A Human genes 0.000 description 1
• 101710117490 Circumsporozoite protein Proteins 0.000 description 1
• 108010003384 Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102000004626 Colony-Stimulating Factor Receptors Human genes 0.000 description 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 102000008198 Coxsackie and Adenovirus Receptor Like Membrane Protein Human genes 0.000 description 1
• 108010035601 Coxsackie and Adenovirus Receptor Like Membrane Protein Proteins 0.000 description 1
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
• 102000003849 Cytochrome P450 Human genes 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• 108010069091 Dystrophin Proteins 0.000 description 1
• 102000001039 Dystrophin Human genes 0.000 description 1
• 101150029662 E1 gene Proteins 0.000 description 1
• 101150082674 E2 gene Proteins 0.000 description 1
• 108010093502 E2F Transcription Factors Proteins 0.000 description 1
• 102000001388 E2F Transcription Factors Human genes 0.000 description 1
• 101710201734 E3 protein Proteins 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 101150029707 ERBB2 gene Proteins 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 1
• 102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
• 241000709661 Enterovirus Species 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 101710091919 Eukaryotic translation initiation factor 4G Proteins 0.000 description 1
• 108091008794 FGF receptors Proteins 0.000 description 1
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
• 102100026559 Filamin-B Human genes 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 1
• 102400000921 Gastrin Human genes 0.000 description 1
• 102000004862 Gastrin releasing peptide Human genes 0.000 description 1
• 108090001053 Gastrin releasing peptide Proteins 0.000 description 1
• 102100036519 Gastrin-releasing peptide Human genes 0.000 description 1
• 108010052343 Gastrins Proteins 0.000 description 1
• 102000013382 Gelatinases Human genes 0.000 description 1
• 108010026132 Gelatinases Proteins 0.000 description 1
• 101710169915 General vesicular transport factor p115 Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 108050002220 Green fluorescent protein, GFP Proteins 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 208000031220 Hemophilia Diseases 0.000 description 1
• 208000009292 Hemophilia A Diseases 0.000 description 1
• 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
• 102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 1
• 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 1
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 1
• 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 description 1
• 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 description 1
• 101001005717 Homo sapiens Melanoma-associated antigen 12 Proteins 0.000 description 1
• 101001005718 Homo sapiens Melanoma-associated antigen 2 Proteins 0.000 description 1
• 101001005719 Homo sapiens Melanoma-associated antigen 3 Proteins 0.000 description 1
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
• 101000624947 Homo sapiens Nesprin-1 Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 102000016878 Hypoxia-Inducible Factor 1 Human genes 0.000 description 1
• 108010028501 Hypoxia-Inducible Factor 1 Proteins 0.000 description 1
• 108010031794 IGF Type 1 Receptor Proteins 0.000 description 1
• 102000038455 IGF Type 1 Receptor Human genes 0.000 description 1
• 108010031792 IGF Type 2 Receptor Proteins 0.000 description 1
• 102000038460 IGF Type 2 Receptor Human genes 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
• 102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
• 102000014429 Insulin-like growth factor Human genes 0.000 description 1
• 108010008212 Integrin alpha4beta1 Proteins 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 102000000646 Interleukin-3 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 102000000585 Interleukin-9 Human genes 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 101150113776 LMP1 gene Proteins 0.000 description 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
• 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
• 102100026238 Lymphotoxin-alpha Human genes 0.000 description 1
• 102100026894 Lymphotoxin-beta Human genes 0.000 description 1
• 108090000362 Lymphotoxin-beta Proteins 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108010000410 MSH receptor Proteins 0.000 description 1
• 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
• 108010058398 Macrophage Colony-Stimulating Factor Receptor Proteins 0.000 description 1
• 101710175243 Major antigen Proteins 0.000 description 1
• 108010031099 Mannose Receptor Proteins 0.000 description 1
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
• 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 description 1
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
• 102100025084 Melanoma-associated antigen 12 Human genes 0.000 description 1
• 102100025081 Melanoma-associated antigen 2 Human genes 0.000 description 1
• 102100025082 Melanoma-associated antigen 3 Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 description 1
• 108010050619 Monokines Proteins 0.000 description 1
• 102000013967 Monokines Human genes 0.000 description 1
• 108010063954 Mucins Proteins 0.000 description 1
• 101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
• 101100346932 Mus musculus Muc1 gene Proteins 0.000 description 1
• 101000686934 Mus musculus Prolactin-7D1 Proteins 0.000 description 1
• 101000822667 Mus musculus Something about silencing protein 10 Proteins 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• BKAYIFDRRZZKNF-VIFPVBQESA-N N-acetylcarnosine Chemical compound CC(=O)NCCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BKAYIFDRRZZKNF-VIFPVBQESA-N 0.000 description 1
• 102100023306 Nesprin-1 Human genes 0.000 description 1
• 102000004459 Nitroreductase Human genes 0.000 description 1
• 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 101000989950 Otolemur crassicaudatus Hemoglobin subunit alpha-A Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
• 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
• 108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
• 102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 description 1
• 229930012538 Paclitaxel Natural products 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000005877 Peptide Initiation Factors Human genes 0.000 description 1
• 108010044843 Peptide Initiation Factors Proteins 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 102100035846 Pigment epithelium-derived factor Human genes 0.000 description 1
• 108010001014 Plasminogen Activators Proteins 0.000 description 1
• 102000001938 Plasminogen Activators Human genes 0.000 description 1
• 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
• 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
• 241000223960 Plasmodium falciparum Species 0.000 description 1
• 102100030304 Platelet factor 4 Human genes 0.000 description 1
• 108090000778 Platelet factor 4 Proteins 0.000 description 1
• 208000002151 Pleural effusion Diseases 0.000 description 1
• 108010076039 Polyproteins Proteins 0.000 description 1
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
• 102000003946 Prolactin Human genes 0.000 description 1
• 108010057464 Prolactin Proteins 0.000 description 1
• 102000007327 Protamines Human genes 0.000 description 1
• 108010007568 Protamines Proteins 0.000 description 1
• 102000009572 RNA Polymerase II Human genes 0.000 description 1
• 108010009460 RNA Polymerase II Proteins 0.000 description 1
• 101100409194 Rattus norvegicus Ppargc1b gene Proteins 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 108090000783 Renin Proteins 0.000 description 1
• 102100028255 Renin Human genes 0.000 description 1
• 241001068263 Replication competent viruses Species 0.000 description 1
• 102400001051 Restin Human genes 0.000 description 1
• 201000000582 Retinoblastoma Diseases 0.000 description 1
• 102000034527 Retinoid X Receptors Human genes 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 108010039491 Ricin Proteins 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 101710188106 SEC14-like protein 2 Proteins 0.000 description 1
• 101100123443 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HAP4 gene Proteins 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 206010067868 Skin mass Diseases 0.000 description 1
• 102000039471 Small Nuclear RNA Human genes 0.000 description 1
• 108020004688 Small Nuclear RNA Proteins 0.000 description 1
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
• 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 102000005157 Somatostatin Human genes 0.000 description 1
• 108010056088 Somatostatin Proteins 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 102400000096 Substance P Human genes 0.000 description 1
• 101800003906 Substance P Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 101000946719 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Carboxysome assembly protein CcmN Proteins 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 102000006467 TATA-Box Binding Protein Human genes 0.000 description 1
• 108010044281 TATA-Box Binding Protein Proteins 0.000 description 1
• 108700012411 TNFSF10 Proteins 0.000 description 1
• 102100032938 Telomerase reverse transcriptase Human genes 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 101710137710 Thioesterase 1/protease 1/lysophospholipase L1 Proteins 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 102000002938 Thrombospondin Human genes 0.000 description 1
• 108060008245 Thrombospondin Proteins 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• 102000006290 Transcription Factor TFIID Human genes 0.000 description 1
• 108010083268 Transcription Factor TFIID Proteins 0.000 description 1
• 108010033576 Transferrin Receptors Proteins 0.000 description 1
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
• 101000980463 Treponema pallidum (strain Nichols) Chaperonin GroEL Proteins 0.000 description 1
• 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
• 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
• 102100034300 Tryptophan-tRNA ligase, cytoplasmic Human genes 0.000 description 1
• 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
• 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
• 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
• 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 1
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 102400000731 Tumstatin Human genes 0.000 description 1
• 108010046334 Urease Proteins 0.000 description 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
• 102100038851 Uroplakin-2 Human genes 0.000 description 1
• 101710173761 Uroplakin-2 Proteins 0.000 description 1
• 102100038854 Uroplakin-3a Human genes 0.000 description 1
• 108050004295 Uroplakin-3a Proteins 0.000 description 1
• 108091008605 VEGF receptors Proteins 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000001919 adrenal effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000032683 aging Effects 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• NIGUVXFURDGQKZ-KRAHZTDDSA-N alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O NIGUVXFURDGQKZ-KRAHZTDDSA-N 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 230000003302 anti-idiotype Effects 0.000 description 1
• 230000005809 anti-tumor immunity Effects 0.000 description 1
• 230000006023 anti-tumor response Effects 0.000 description 1
• 239000003816 antisense DNA Substances 0.000 description 1
• 229960005348 antithrombin iii Drugs 0.000 description 1
• 239000012062 aqueous buffer Substances 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 108010006523 asialoglycoprotein receptor Proteins 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 239000012131 assay buffer Substances 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 108700000707 bcl-2-Associated X Proteins 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 208000026900 bile duct neoplasm Diseases 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 230000004071 biological effect Effects 0.000 description 1
• 238000001815 biotherapy Methods 0.000 description 1
• DNDCVAGJPBKION-DOPDSADYSA-N bombesin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1NC2=CC=CC=C2C=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CN=CN1 DNDCVAGJPBKION-DOPDSADYSA-N 0.000 description 1
• 239000012888 bovine serum Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 235000011148 calcium chloride Nutrition 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 230000005907 cancer growth Effects 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 238000001516 cell proliferation assay Methods 0.000 description 1
• 238000002659 cell therapy Methods 0.000 description 1
• 230000003833 cell viability Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
• 239000007795 chemical reaction product Substances 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 235000019693 cherries Nutrition 0.000 description 1
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
• 238000012761 co-transfection Methods 0.000 description 1
• 239000003184 complementary RNA Substances 0.000 description 1
• 230000030944 contact inhibition Effects 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 239000013256 coordination polymer Substances 0.000 description 1
• 238000005138 cryopreservation Methods 0.000 description 1
• 210000004748 cultured cell Anatomy 0.000 description 1
• 108010045325 cyclic arginine-glycine-aspartic acid peptide Proteins 0.000 description 1
• 229960004397 cyclophosphamide Drugs 0.000 description 1
• 102000003675 cytokine receptors Human genes 0.000 description 1
• 108010038764 cytoplasmic linker protein 170 Proteins 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 239000000824 cytostatic agent Substances 0.000 description 1
• 238000002784 cytotoxicity assay Methods 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000000994 depressogenic effect Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 102000038379 digestive enzymes Human genes 0.000 description 1
• 108091007734 digestive enzymes Proteins 0.000 description 1
• 230000003292 diminished effect Effects 0.000 description 1
• 206010013023 diphtheria Diseases 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
• 230000008034 disappearance Effects 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 231100000673 dose–response relationship Toxicity 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000002357 endometrial effect Effects 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 239000002532 enzyme inhibitor Substances 0.000 description 1
• 108060002566 ephrin Proteins 0.000 description 1
• 102000012803 ephrin Human genes 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 208000021045 exocrine pancreatic carcinoma Diseases 0.000 description 1
• 108010052621 fas Receptor Proteins 0.000 description 1
• 102000018823 fas Receptor Human genes 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• PUBCCFNQJQKCNC-XKNFJVFFSA-N gastrin-releasingpeptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O)C(C)C)C1=CNC=N1 PUBCCFNQJQKCNC-XKNFJVFFSA-N 0.000 description 1
• 238000012239 gene modification Methods 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 230000005017 genetic modification Effects 0.000 description 1
• 235000013617 genetically modified food Nutrition 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 235000004554 glutamine Nutrition 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 210000003714 granulocyte Anatomy 0.000 description 1
• 230000009036 growth inhibition Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 201000005787 hematologic cancer Diseases 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 239000001257 hydrogen Substances 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000002390 hyperplastic effect Effects 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000008105 immune reaction Effects 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 230000000415 inactivating effect Effects 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000036512 infertility Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 210000005228 liver tissue Anatomy 0.000 description 1
• 238000003468 luciferase reporter gene assay Methods 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
• 229960004857 mitomycin Drugs 0.000 description 1
• 230000011278 mitosis Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 210000000492 nasalseptum Anatomy 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000006654 negative regulation of apoptotic process Effects 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 108020001162 nitroreductase Proteins 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 229940023146 nucleic acid vaccine Drugs 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 150000002894 organic compounds Chemical class 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000003002 pH adjusting agent Substances 0.000 description 1
• 229960001592 paclitaxel Drugs 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 239000013618 particulate matter Substances 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 238000012335 pathological evaluation Methods 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 238000002205 phenol-chloroform extraction Methods 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 229910052698 phosphorus Inorganic materials 0.000 description 1
• 108090000102 pigment epithelium-derived factor Proteins 0.000 description 1
• 210000002381 plasma Anatomy 0.000 description 1
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 239000001103 potassium chloride Substances 0.000 description 1
• 235000011164 potassium chloride Nutrition 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000000861 pro-apoptotic effect Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 229940097325 prolactin Drugs 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 201000001514 prostate carcinoma Diseases 0.000 description 1
• 229950008679 protamine sulfate Drugs 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000005855 radiation Effects 0.000 description 1
• 239000002516 radical scavenger Substances 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000009711 regulatory function Effects 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 238000002271 resection Methods 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000000979 retarding effect Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 238000013207 serial dilution Methods 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000001632 sodium acetate Substances 0.000 description 1
• 235000017281 sodium acetate Nutrition 0.000 description 1
• 229910000029 sodium carbonate Inorganic materials 0.000 description 1
• 239000001540 sodium lactate Substances 0.000 description 1
• 229940005581 sodium lactate Drugs 0.000 description 1
• 235000011088 sodium lactate Nutrition 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 210000004872 soft tissue Anatomy 0.000 description 1
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
• 229960000553 somatostatin Drugs 0.000 description 1
• 238000002798 spectrophotometry method Methods 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 230000002195 synergetic effect Effects 0.000 description 1
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
• 108010057210 telomerase RNA Proteins 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 239000006163 transport media Substances 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 239000002753 trypsin inhibitor Substances 0.000 description 1
• 229940038237 tumor antigen vaccine Drugs 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 230000005851 tumor immunogenicity Effects 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 239000000225 tumor suppressor protein Substances 0.000 description 1
• 108010012374 type IV collagen alpha3 chain Proteins 0.000 description 1
• 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 210000000689 upper leg Anatomy 0.000 description 1
• 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 230000002227 vasoactive effect Effects 0.000 description 1
• 108010060757 vasostatin Proteins 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 230000035899 viability Effects 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 230000003442 weekly effect Effects 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1